The present study was designed to investigate the cardiac benefits of M 3 muscarinic receptor (M 3 -mAChR) overexpression and whether these effects are related to the regulation of the inward rectifying K + channel by microRNA-1 (miR-1) in a conditional overexpression mouse model. A cardiac-specific M 3 -mAChR transgenic mouse model was successfully established for the first time in this study using microinjection, and the overexpression was confirmed by both reverse transcriptase-polymerase chain reaction and Western blot techniques. We demonstrated that M 3 -mAChR overexpression dramatically reduced the incidence of arrhythmias and decreased the mortality in a mouse model of myocardial ischemia-reperfusion (I/R). By using whole-cell patch techniques, M 3 -mAChR overexpression significantly shortened the action potential duration and restored the membrane repolarization by increasing the inward rectifying K + current. By using Western blot techniques, M 3 -mAChR overexpression also rescued the expression of the inward rectifying K + channel subunit Kir2.1 after myocardial I/R injury. This result was accompanied by suppression of upregulation miR-1. We conclude that M 3 -mAChR overexpression reduced the incidence of arrhythmias and mortality after myocardial I/R by protecting the myocardium from ischemia in mice. This effect may be mediated by increasing the inward rectifying K + current by downregulation of arrhythmogenic miR-1 expression, which might partially be a novel strategy for antiarrhythmias, leading to sudden cardiac death.
INTRODUCTION
Sudden cardiac death is a major contributor to mortality in industrialized nations, affecting around 500,000 individuals annually in the Western world. It can also cause more deaths than acquired immunodeficiency syndrome (AIDS), lung and breast cancer and stroke combined (1) . In China, preliminary data suggest that there are over 544,000 adults with sudden cardiac death each year (2) . About 75% of the sudden cardiac death cases are linked to a previous myocardial infarction, and 80% show a clinical record with the history of coronary artery disease (2) . Intriguingly, life-threatening cardiac arrhythmias, one of the leading causes of sudden cardiac death, have been clinically demonstrated in the vast majority of severe heart diseases, especially myocardial infarction. Unfortunately, inefficacy of conventional antiarrhythmic drugs has also been recognized in healing the electrical remodeling process or reducing sudden cardiac death (3, 4) . Therefore, the primary purpose of the present study was designed to develop rational approaches to prevent lethal cardiac arrhythmias that may lead to a consequent sudden cardiac death.
Since the initial identification of the M 3 subtype of the muscarinic acetylcholine receptors (M 3 -mAChR) in the heart, there have been increasing interest and advances in studies on the pathophysiological roles of M 3 -mAChR in the heart (5) . Recent studies from several laboratories have provided compelling and solid evidence in support of the important roles of M 3 -mAChR in the regulation and maintenance of cardiac function and heart disease (6) (7) (8) . chemic dysrhythmias) (9) . M 3 -mAChR interacts with gap-junctional channel connexin 43 to maintain cell-cell communication and excitation propagation (10) . M 3 -mAChR regulates intracellular phosphoinositide hydrolysis to improve cardiac contraction and hemodynamic function (11) . M 3 -mAChR also activates antiapoptotic signaling molecules, enhances endogenous antioxidant capacity and diminishes intracellular Ca 2+ overload, all of which contribute to protecting the heart against ischemic injuries (12) . However, it is generally difficult to predict the simultaneous involvement of two or more mAChR subtypes in a specific functional response by using antagonists of limited subtype selectivity. Development of transgenic mice overexpressing specific mAChR subtypes seems to allow a more definitive approach to defining the pathophysiological roles of mAChRs. To further explore the potential roles of M 3 -mAChR in myocardial ischemia and sudden cardiac death, we created a transgenic mouse model in which M 3 -mAChR was overexpressed conditionally.
Overexpression of M 3 Muscarinic Receptor Is a Novel Strategy for Preventing Sudden Cardiac Death in Transgenic Mice
There is a growing body of evidence showing that the dysfunction of the potassium channel is closely related to cardiac diseases (13) . Among them, the Kir family, which expresses two transmembrane-spanning segments flanking a conserved pore region, is structurally and functionally different from other ion channels. Kir2.1 subunits, encoded by the potassium inwardlyrectifying channel, subfamily J, member 2 (KCNJ2) gene, is the main K + channel subunit that mediates inward rectifier potassium channel current (I K1 ) in cardiomyocytes (14) , which plays a key role in setting up the resting membrane potentials and in the repolarization of cardiac myocytes, especially affecting the action potential duration (APD) at 90% repolarization (APD 90 ) (15) . Many studies have demonstrated that I K1 is dysfunctional in several cardiac diseases such as cardiac ischemia-reperfusion (I/R) injury, arrhythmia and heart failure (16) (17) (18) .
Since the discovery of microRNA, a single-stranded noncoding RNA of approximately 22 nucleotides long and >700 miRNAs have been identified in humans (19) , which regulates up to 20-30% of gene expression by binding to 3′ untranslated regions (UTRs) of mRNAs through inexact sequence matching, targeting numerous mRNAs for translational inhibition or degradation (20) . For example, the overexpressed microRNA-1 (miR-1) is arrhythmogenic either in ischemic or normal hearts, which could slow the conduction and depolarized the cytoplasmic membrane by posttranscriptionally repressing KCNJ2 (21) .
This study was designed to investigate the cardiac beneficial effects of M 3 -mAChR overexpression and whether they are related to the regulation of inward rectifying K + channel by miR-1 and how the molecular processes within the cardiac cell are controlled after the overexpression of M 3 -mAChR. These can definitely help us better understanding the pathology of myocardial ischemia that are associated with the regulation of gene expression and transcriptional activity, which also might be a novel strategy for preventing sudden cardiac death.
MATERIALS AND METHODS

Vector Construction and Generation of M 3 -mAChR Transgenic Mouse
The cDNA (1,836 bp) of M 3 -mAChR from the University of Missouri-Roller (UMR) cDNA Resource Center (www.cdna.org) was cloned into α-myosin heavy chain (α-MHC) vector (a gift from Dr J. Robbins, Children's Hospital Research Foundation, Cincinnati, OH, USA). M 3 -mAChR cDNA was subcloned between SalI and HindIII of the α-MHC expression cassette. The construct also contains a human growth hormone polyadenylylation (Hgh polyA) sequence. The M 3 -mAChR cDNA was amplified by the PCR, and the vector was extracted and cut using the SpeI restriction enzyme ( Figure 1A) . The DNA was then prepared for microinjection to produce transgenic mouse via cDNA microinjection of fertilized 562-L oocytes according to established techniques (22) (see the online supplementary materials).
Mouse Model of Myocardial Ischemia Reperfusion
The 562-L male M 3 transgenic (M 3 Tg) mice and their wild-type (WT) littermates, weighing approximately 25 g, were subjected to the sham or myocardial I/R model as previously described (23) . The ECG and mortality were observed in each group to evaluate the severity of arrhythmia. Then, the hearts were removed for ventricular cardiomyocyte isolation, Western blot and realtime reverse transcriptase-polymerase chain reaction (RT-PCR) assay. This study was approved and supervised by the Institutional Animal Care and Use Committee of Harbin Medical University. Use of animals was in accordance with the regulations of the ethic committees of Harbin Medical University and was confirmed with the Guide for the Care and Use of Laboratory Animals, published by the U.S. National Institutes of Health (NIH publication no. 85-23, revised 1996) (see the online supplementary materials).
Arrhythmia Scores
The incidence of arrhythmias and the mortality rate were registered and evaluated for a continuous period of 2 h after myocardial I/R injury or sham surgery. An arrhythmia score was used to include the incidence and duration of arrhythmias by giving a grade to the animals (24) (see the online supplementary materials).
Arrhythmic Model Induced by Aconitine in Mice
Aconitine (5 mg/mL, 2 μg/10 g mice; Sigma, St. Louis, MO, USA) was pumped at a constant speed using Longerpump (LSP02-1B; Baoding Longer Precision Pump Company, Baoding, China) to induce the ventricular arrhythmias within 4 min. In each group, the arrhythmia was observed until the death of the mice. The survival time was estimated in WT and M 3 Tg mice.
Ventricular Cardiomyocyte Isolation and Patch-Clamp Recording
The dissociation procedures for ventricular cardiomyocytes were similar to that described previously (24) . The cardiomyocytes were transferred to a chamber mounted on an inverted microscope (Nikon Diaphot; Nikon, Tokyo, Japan) for electrophysiological recording. Action potential (AP) and potassium currents (K + ) were recorded under current and voltage-clamp configuration, respectively, using the whole-cell patch-clamp technique with an Axopatch 200B amplifier (Axon Instruments, Foster City, CA, USA) (see the online supplementary materials).
Western Blot Analysis
The procedures for membrane protein extraction from ventricular tissue and immunoblotting are described in detail elsewhere (12) . The primary antibodies of anti-Kir2.1, anti-Kv4.2 (Alomone Labs, Jerusalme, Israel), and anti-Cav1.2, anti-M 3 (Santa Cruz Technology, Santa Cruz, CA, USA), were used, with GAPDH (anti-GAPDH antibody from Kangcheng, Shanghai, China) as an internal control. Western blot bands were quantified using Odyssey v1.2 software by measur- 
Data Analysis
Average data were expressed as mean ± standard error of the mean (SEM). Statistical comparisons (performed using analysis of variance [ANOVA]) were carried out using SPSS 13.0. A two-tailed P value <0.05 indicated a statistically significant difference. Nonlinear least-square curve fitting was performed with CLAMPFIT in pCLAMP 10.0 or GraphPad Prism.
All supplementary materials are available online at www.molmed.org.
RESULTS
Characterization of M 3 -mAChR in Tg Mice
Our data showed that the mRNA levels of M 3 -mAChR were higher in M 3 -overexpressing mice than in their WT counterparts ( Figure 1B ; P < 0.01). Meanwhile, the protein expression of M 3 -mAChR in M 3 -overexpressing mice (1.56 ± 0.17) was also higher than that in WT mice ( Figure 1C ; P < 0.05). To further confirm the successful establish- The average data presented were mean ± SEM; *P < 0.05, **P < 0.01 versus WT. ment of M 3 -mAChR overexpression, whole-cell patch-clamp experiments were performed using ventricular cardiomyo cytes in the presence of 2 mmol/L 4-aminopyridine (4-AP) in the perfusate to antecedently block the transient outward rapid K + current (I to ).
As shown in Figures 1D and E 
Cardiac Beneficial Effects of M 3 -mAChR Overexpression against Mice Myocardial I/R and Aconitine Injury
To detect the protective role of overexpression of M 3 -mAChR in myocardial I/R injury, the WT and M 3 Tg mice were subjected to 30 min of ischemia and then 2 h of reperfusion. Representative electrocardiogram after myocardial I/R is shown in Figure 2A , and the abnormalities included ventricular fibrillation, ventricular tachyarrhythmia, premature ventricular contraction, bigeminy and atrioventricular block. The onset of atrial ventricular block after myocardial I/R injury in M 3 Tg mice (58.4 ± 15.3 min) were prolonged compared with that in WT I/R mice (17.4 ± 5.6 min, P < 0.01). The duration of atrial ventricular block in M 3 Tg I/R mice (7.27 ± 2.56 min) was just slightly shortened compared with that in WT I/R mice (11.8 ± 2.2 min), but there was no statistical significance. Overexpression of M 3 -mAChR lowered the arrhythmia score after myocardial I/R from 3.56 ± 0.39 (n = 32 for WT I/R mice) to 1.78 ± 0.31 (n = 33 for M 3 Tg I/R mice, P < 0.01). The mortality rate was then determined as the percentage of mice that initially recovered from surgery but subsequently died. M 3 Tg I/R mice tended to have a lower mortality rate: 9% (3 out of 33) for the M 3 Tg I/R mice versus 28% (9 out of 32) for the WT I/R mice ( Figure 2E) . None of the sham M 3 Tg mice or WT controls died during or after the operation.
Aconitine is a highly poisonous alkaloid derived from various aconite species and is used for creating models of cardiac arrhythmia (25) . The arrhythmia was also induced by aconitine, and the survival time was obviously prolonged in M 3 Tg mice compared with WT mice ( Figure 2G ; P < 0.01). Figure 3B , bottom right panel). Action potential duration at 50% (APD 50 ) was not significantly changed between strains in all groups ( Figure 3B , bottom left panel). We also measured the ratio of APD 50 /APD 90 and found no significant difference in different experimental groups (data not shown). Comparison of AP characteristics of ventricular cardiomyocytes from both WT and M 3 Tg mice with or without myocardial I/R were summarized in Table 1 . D 1 7 ( 1 1 -1 2 ) 1 1 7 9 -1 1 8 7 , N hearts. Figure 4A showed typical examples of I K1 , which was elicited by a series of 300-ms depolarizing test potentials (TP) from -120 to +50 mV, with 10-mV increments from a holding potential (HP) of -40 mV. I K1 was substantially increased in M 3 Tg compared with that in WT mice, as illustrated in Figure 4B (P < 0.05, n = 10 cells from six mice). While I K1 from both M 3 Tg I/R and WT I/R mice was substantially decreased, the current density of I K1 in M 3 Tg I/R mice was higher than that in WT I/R mice (see Figure 4B ; P < 0.05; n = 10 cells from six mice). I to was defined as the difference between the peak outward current (I peak ) and the sustained component remaining (I peak ) at the end of the depolarizing pulse (I to = I peak -I sus ). The mean currentvoltage relationship for I to was illustrated in Figure 4D . I to current density was not significantly changed between strains in all groups (Figures 4C, D Figure 5A ). Although the decreases in Kir2.1 was confirmed in ventricular cardiomyocytes from both M 3 Tg I/R and WT I/R mice, the expression level of Kir2.1 was much higher in M 3 Tg I/R mice than in WT I/R mice (P < 0.05). However, mRNA levels of KCNJ2 (encodes Kir2.1) were similar between strains in all groups (P > 0.05; Figure 5D ). As expected, there were no significant differences observed in the mRNA and protein expressions of Kv4.2 (mediates I to in cardiomyocytes) under the current experimental condition (P > 0.05; Fig- ures 5B, E; n = 8). The mRNA levels of CACNA1C (encodes Cav1.2) was much higher in M 3 Tg I/R mice than in WT I/R mice (P < 0.01; Figure 5F ). However, Cav1.2 (195 kDa), the major component of the L-type calcium channel, remained unchanged among four groups (P > 0.05; Figure 5C ).
O V E M B E R -D E C E M B E R 2 0 1 1 O V E R E X P R E S S I O N O F M 3 R E C E P T O R P R E V E N T S S U D D E N C A R D I A C D E
M 3 -mAChR Overexpression Suppressed Upregulated miR-1 Induced by Myocardial I/R Injury
Our previous study has established KCNJ2 as a target of miR-1, and miR-1 is considered as a muscle-specific miRNA that plays an important role in ischemic arrhythmogenesis (21) . Here, we detected the expression level of miR-1 by using qRT-PCR. Interestingly, the miR-1 expression was decreased in the myocardium of M 3 Tg compared with WT hearts (n = 5; P < 0.05; Figure 6B ). Whereas the miR-1 levels were significantly increased after myocardial I/R injury in both WT and M 3 Tg mice, levels in M 3 Tg mice after myocardial I/R injury D 1 7 ( 1 1 -1 2 ) 1 1 7 9 -1 1 8 7 , N were obviously lower than those in the WT group (P < 0.01; Figure 6A) .
R E S E A R C H A R T I C L E M O L M E
DISCUSSION
Here we demonstrate that cardiac overexpression of M 3 -mAChR plays a critical role in the reduction of the incidence of arrhythmias and mortality in a mouse model by protecting the myocardium from ischemia, increasing the survival time after aconitine treatment and decreasing the arrhythmic score after myocardial I/R. Our patch-clamp data also demonstrate that M 3 -mAChR overexpression significantly shortened the APD by increasing the I K1 and consequently enhancing the membrane stability of ventricular cardiomyocytes without affecting I to . More importantly, our molecular study clearly showed that the Kir2.1 was upregulated and miR-1 expression was downregulated in the myocardium from M 3 -overexpressing mice. This molecular evidence further confirmed our electrophysiological study. These findings not only help us understand the mechanisms underlying the cardioprotective effects of M 3 -mAChR from ischemia, but also conceptually advance our view of miRNAs that may serve as potential therapeutic and drug targets.
There are important fundamental implications of our findings. First, a large body of evidence indicates that muscarinic acetylcholine receptors, especially M 3 -mAChR, play critical roles in regulating the activity of many important functions of cardiovascular systems (26) . Previous studies have demonstrated that M 3 -mAChR may possess a potential role in protecting the heart against ischemia through multiple mechanisms, including the interaction with gap junction channel connexin 43 to maintain cell-cell communication (10) , activation of antiapoptotic signal molecule Bcl-2 and p38 mitogen-activated protein kinase and a decrease in Ca 2+ overload induced by myocardial ischemia in ventricular cardiomyocytes (12) , which has been known to improve cardiac contraction and hemodynamics by activating intracellular phosphoinositide hydrolysis via a Gq pathway (27) .
Second, our study is the first to our knowledge to demonstrate that an M 3 Tg, specifically expressed in cardiac tissues, was successfully established and it is a useful animal model to study the M 3 -mAChR functions on cardiac diseases. The successful establishment of M 3 Tg was confirmed by its positive genotype of M 3 -mAChR by PCR data confirming much higher mRNA and protein expressions, and more importantly, the current density of I KM3 mediated by M 3 -mAChR was increased by an M 3 -mAChR agonist in the ventricular cardiomyocytes (Figure 1) . Most importantly, the overexpression of M 3 -mAChR significantly reduced the incidence of arrhythmias induced by myocardial I/R, sequentially decreased the mortality of myocardial I/R and improved the survival time (Figure 2 ). These data significantly enhanced knowledge of the potential roles of M 3 -mAChR in myocardium against myocardial I/R injury, and this knowledge has been demonstrated by many researchers (28) (29) (30) (31) .
Myocardial ischemia results in a dramatic disorder of automaticity, in an increased heterogeneity of conduction and structural remodeling and in alterations of ion channel protein expression and distribution (32) . These results contribute to the development of an electrical disturbance that leads to life-threatening cardiac arrhythmias. To explore the underlying ion channel mechanisms of M 3 -mAChR in its cardiac protection against myocardial I/R injury, the APD and some currents responsible for the characteristic differences in AP wave shapes were also examined. (Figures 4 and 5) . These results suggest that M 3 -mAChR overexpression plays, at least in part, an important role in cardioprotection. Under normal conditions, cardiac I K1 dominates the K + conductance near the RMP. In accordance with this theory, our current-clamp data demonstrate that the greater the outward currents of I K1 , the shorter the APD. It is also well known that I K1 stabilizes the RMP and determines the cell input resistance, which is the resistance of the membrane in the subthreshold voltage range (33) . Other researches have reported that I K1 is downregulated in several other cardiac disorders such as heart failure and long QT syndrome (34, 35) . The downregulation of I K1 is also observed in the models of cardiac hypertrophy and in the patients with cardiomyopathies (36) . This downregulation of I K1 has greater impacts on life-threatening arrhythmias due to membrane depolarization, APD prolongation, and both early and delayed after depolarizations (17) . It has been known that KCNJ2, which encodes the cardiac I K1 channels, is responsible for setting and maintaining the cardiac RMP. Although the protein level for Kir2.1 was obviously different, there were no detectable changes of KCNJ2 among the four experimental groups ( Figure 5 ). This discrepancy between mRNA and protein levels may come from the function of microRNA, such as miR-1, which displayed opposite trends compared with the Kir2.1 protein level. As many studies have reported (21,37), 
